The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema

Emil Zeynalov, Chih Hung Chen, Stanley C. Froehner, Marvin E. Adams, Ole Petter Ottersen, Mahmood Amiry-Moghaddam, Anish Bhardwaj

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

OBJECTIVE: Osmotherapy with hypertonic saline ameliorates cerebral edema associated with experimental ischemic stroke. We tested the hypothesis that hypertonic saline exerts its antiedema effect by promoting an efflux of water from brain via the perivascular aquaporin-4 pool. We used mice with targeted disruption of the gene encoding α-syntrophin (α-Syn) that lack the perivascular aquaporin-4 pool but retain the endothelial pool of this protein. DESIGN: Prospective laboratory animal study. SETTING: Research laboratory in a university teaching hospital. MEASUREMENTS AND MAIN RESULTS: Halothane-anesthetized adult male wildtype C57B/6 and α-Syn mice were subjected to 90 min of transient middle cerebral artery occlusion and treated with either a continuous intravenous infusion of 0.9% saline or 3% hypertonic saline (1.5 mL/kg/hr) for 48 hr. In the first series of experiments (n = 59), increased brain water content analyzed by wet-to-dry ratios in the ischemic hemisphere of wildtype mice was attenuated after hypertonic saline (79.9% ± 0.5%; mean ± sem) but not after 0.9% saline (82.3% ± 1.0%) treatment. In contrast in α-Syn mice, hypertonic saline had no effect on the postischemic edema (hypertonic saline: 80.3% ± 0.7%; 0.9% saline: 80.3% ± 0.4%). In the second series of experiments (n = 32), treatment with hypertonic saline attenuated postischemic blood-brain barrier disruption at 48 hr in wildtype mice but not in α-Syn mice; α-Syn deletion alone had no effect on blood-brain barrier integrity. In the third series of experiments (n = 34), α-Syn mice treated with either hypertonic saline or 0.9% saline had smaller infarct volume as compared with their wildtype counterparts. CONCLUSIONS: These data demonstrate that 1) osmotherapy with hypertonic saline exerts antiedema effects via the perivascular pool of aquaporin-4, 2) hypertonic saline attenuates blood-brain barrier disruption depending on the presence of perivascular aquaporin-4, and 3) deletion of the perivascular pool of aquaporin-4 alleviates tissue damage after stroke, in mice subjected to osmotherapy and in nontreated mice.

Original languageEnglish (US)
Pages (from-to)2634-2640
Number of pages7
JournalCritical Care Medicine
Volume36
Issue number9
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Aquaporin 4
Brain Edema
Blood-Brain Barrier
Aquaporin 3
Stroke
Aquaporin 2
Water
Middle Cerebral Artery Infarction
Brain
Laboratory Animals
Halothane
Intravenous Infusions
Teaching Hospitals
Edema

Keywords

  • Aquaporins
  • Astrocyte
  • Cerebral edema
  • Focal cerebral ischemia
  • Infarct
  • Osmotherapy
  • Reperfusion
  • Stroke

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Zeynalov, E., Chen, C. H., Froehner, S. C., Adams, M. E., Ottersen, O. P., Amiry-Moghaddam, M., & Bhardwaj, A. (2008). The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. Critical Care Medicine, 36(9), 2634-2640. https://doi.org/10.1097/CCM.0b013e3181847853

The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. / Zeynalov, Emil; Chen, Chih Hung; Froehner, Stanley C.; Adams, Marvin E.; Ottersen, Ole Petter; Amiry-Moghaddam, Mahmood; Bhardwaj, Anish.

In: Critical Care Medicine, Vol. 36, No. 9, 09.2008, p. 2634-2640.

Research output: Contribution to journalArticle

Zeynalov, E, Chen, CH, Froehner, SC, Adams, ME, Ottersen, OP, Amiry-Moghaddam, M & Bhardwaj, A 2008, 'The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema', Critical Care Medicine, vol. 36, no. 9, pp. 2634-2640. https://doi.org/10.1097/CCM.0b013e3181847853
Zeynalov E, Chen CH, Froehner SC, Adams ME, Ottersen OP, Amiry-Moghaddam M et al. The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. Critical Care Medicine. 2008 Sep;36(9):2634-2640. https://doi.org/10.1097/CCM.0b013e3181847853
Zeynalov, Emil ; Chen, Chih Hung ; Froehner, Stanley C. ; Adams, Marvin E. ; Ottersen, Ole Petter ; Amiry-Moghaddam, Mahmood ; Bhardwaj, Anish. / The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. In: Critical Care Medicine. 2008 ; Vol. 36, No. 9. pp. 2634-2640.
@article{c36721e705a54c10b5a21f236f19552f,
title = "The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema",
abstract = "OBJECTIVE: Osmotherapy with hypertonic saline ameliorates cerebral edema associated with experimental ischemic stroke. We tested the hypothesis that hypertonic saline exerts its antiedema effect by promoting an efflux of water from brain via the perivascular aquaporin-4 pool. We used mice with targeted disruption of the gene encoding α-syntrophin (α-Syn) that lack the perivascular aquaporin-4 pool but retain the endothelial pool of this protein. DESIGN: Prospective laboratory animal study. SETTING: Research laboratory in a university teaching hospital. MEASUREMENTS AND MAIN RESULTS: Halothane-anesthetized adult male wildtype C57B/6 and α-Syn mice were subjected to 90 min of transient middle cerebral artery occlusion and treated with either a continuous intravenous infusion of 0.9{\%} saline or 3{\%} hypertonic saline (1.5 mL/kg/hr) for 48 hr. In the first series of experiments (n = 59), increased brain water content analyzed by wet-to-dry ratios in the ischemic hemisphere of wildtype mice was attenuated after hypertonic saline (79.9{\%} ± 0.5{\%}; mean ± sem) but not after 0.9{\%} saline (82.3{\%} ± 1.0{\%}) treatment. In contrast in α-Syn mice, hypertonic saline had no effect on the postischemic edema (hypertonic saline: 80.3{\%} ± 0.7{\%}; 0.9{\%} saline: 80.3{\%} ± 0.4{\%}). In the second series of experiments (n = 32), treatment with hypertonic saline attenuated postischemic blood-brain barrier disruption at 48 hr in wildtype mice but not in α-Syn mice; α-Syn deletion alone had no effect on blood-brain barrier integrity. In the third series of experiments (n = 34), α-Syn mice treated with either hypertonic saline or 0.9{\%} saline had smaller infarct volume as compared with their wildtype counterparts. CONCLUSIONS: These data demonstrate that 1) osmotherapy with hypertonic saline exerts antiedema effects via the perivascular pool of aquaporin-4, 2) hypertonic saline attenuates blood-brain barrier disruption depending on the presence of perivascular aquaporin-4, and 3) deletion of the perivascular pool of aquaporin-4 alleviates tissue damage after stroke, in mice subjected to osmotherapy and in nontreated mice.",
keywords = "Aquaporins, Astrocyte, Cerebral edema, Focal cerebral ischemia, Infarct, Osmotherapy, Reperfusion, Stroke",
author = "Emil Zeynalov and Chen, {Chih Hung} and Froehner, {Stanley C.} and Adams, {Marvin E.} and Ottersen, {Ole Petter} and Mahmood Amiry-Moghaddam and Anish Bhardwaj",
year = "2008",
month = "9",
doi = "10.1097/CCM.0b013e3181847853",
language = "English (US)",
volume = "36",
pages = "2634--2640",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema

AU - Zeynalov, Emil

AU - Chen, Chih Hung

AU - Froehner, Stanley C.

AU - Adams, Marvin E.

AU - Ottersen, Ole Petter

AU - Amiry-Moghaddam, Mahmood

AU - Bhardwaj, Anish

PY - 2008/9

Y1 - 2008/9

N2 - OBJECTIVE: Osmotherapy with hypertonic saline ameliorates cerebral edema associated with experimental ischemic stroke. We tested the hypothesis that hypertonic saline exerts its antiedema effect by promoting an efflux of water from brain via the perivascular aquaporin-4 pool. We used mice with targeted disruption of the gene encoding α-syntrophin (α-Syn) that lack the perivascular aquaporin-4 pool but retain the endothelial pool of this protein. DESIGN: Prospective laboratory animal study. SETTING: Research laboratory in a university teaching hospital. MEASUREMENTS AND MAIN RESULTS: Halothane-anesthetized adult male wildtype C57B/6 and α-Syn mice were subjected to 90 min of transient middle cerebral artery occlusion and treated with either a continuous intravenous infusion of 0.9% saline or 3% hypertonic saline (1.5 mL/kg/hr) for 48 hr. In the first series of experiments (n = 59), increased brain water content analyzed by wet-to-dry ratios in the ischemic hemisphere of wildtype mice was attenuated after hypertonic saline (79.9% ± 0.5%; mean ± sem) but not after 0.9% saline (82.3% ± 1.0%) treatment. In contrast in α-Syn mice, hypertonic saline had no effect on the postischemic edema (hypertonic saline: 80.3% ± 0.7%; 0.9% saline: 80.3% ± 0.4%). In the second series of experiments (n = 32), treatment with hypertonic saline attenuated postischemic blood-brain barrier disruption at 48 hr in wildtype mice but not in α-Syn mice; α-Syn deletion alone had no effect on blood-brain barrier integrity. In the third series of experiments (n = 34), α-Syn mice treated with either hypertonic saline or 0.9% saline had smaller infarct volume as compared with their wildtype counterparts. CONCLUSIONS: These data demonstrate that 1) osmotherapy with hypertonic saline exerts antiedema effects via the perivascular pool of aquaporin-4, 2) hypertonic saline attenuates blood-brain barrier disruption depending on the presence of perivascular aquaporin-4, and 3) deletion of the perivascular pool of aquaporin-4 alleviates tissue damage after stroke, in mice subjected to osmotherapy and in nontreated mice.

AB - OBJECTIVE: Osmotherapy with hypertonic saline ameliorates cerebral edema associated with experimental ischemic stroke. We tested the hypothesis that hypertonic saline exerts its antiedema effect by promoting an efflux of water from brain via the perivascular aquaporin-4 pool. We used mice with targeted disruption of the gene encoding α-syntrophin (α-Syn) that lack the perivascular aquaporin-4 pool but retain the endothelial pool of this protein. DESIGN: Prospective laboratory animal study. SETTING: Research laboratory in a university teaching hospital. MEASUREMENTS AND MAIN RESULTS: Halothane-anesthetized adult male wildtype C57B/6 and α-Syn mice were subjected to 90 min of transient middle cerebral artery occlusion and treated with either a continuous intravenous infusion of 0.9% saline or 3% hypertonic saline (1.5 mL/kg/hr) for 48 hr. In the first series of experiments (n = 59), increased brain water content analyzed by wet-to-dry ratios in the ischemic hemisphere of wildtype mice was attenuated after hypertonic saline (79.9% ± 0.5%; mean ± sem) but not after 0.9% saline (82.3% ± 1.0%) treatment. In contrast in α-Syn mice, hypertonic saline had no effect on the postischemic edema (hypertonic saline: 80.3% ± 0.7%; 0.9% saline: 80.3% ± 0.4%). In the second series of experiments (n = 32), treatment with hypertonic saline attenuated postischemic blood-brain barrier disruption at 48 hr in wildtype mice but not in α-Syn mice; α-Syn deletion alone had no effect on blood-brain barrier integrity. In the third series of experiments (n = 34), α-Syn mice treated with either hypertonic saline or 0.9% saline had smaller infarct volume as compared with their wildtype counterparts. CONCLUSIONS: These data demonstrate that 1) osmotherapy with hypertonic saline exerts antiedema effects via the perivascular pool of aquaporin-4, 2) hypertonic saline attenuates blood-brain barrier disruption depending on the presence of perivascular aquaporin-4, and 3) deletion of the perivascular pool of aquaporin-4 alleviates tissue damage after stroke, in mice subjected to osmotherapy and in nontreated mice.

KW - Aquaporins

KW - Astrocyte

KW - Cerebral edema

KW - Focal cerebral ischemia

KW - Infarct

KW - Osmotherapy

KW - Reperfusion

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=53049097949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53049097949&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e3181847853

DO - 10.1097/CCM.0b013e3181847853

M3 - Article

VL - 36

SP - 2634

EP - 2640

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 9

ER -